Danaher Corporation $DHR Shares Sold by Greenwood Capital Associates LLC

Greenwood Capital Associates LLC lessened its stake in shares of Danaher Corporation (NYSE:DHR) by 77.7% in the 1st quarter, Holdings Channel reports. The institutional investor owned 4,878 shares of the conglomerate’s stock after selling 17,016 shares during the quarter. Greenwood Capital Associates LLC’s holdings in Danaher were worth $925,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of DHR. Bank Pictet & Cie Europe AG grew its holdings in shares of Danaher by 25.4% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock worth $83,895,000 after purchasing an additional 74,301 shares during the last quarter. Maxi Investments CY Ltd purchased a new stake in shares of Danaher in the 3rd quarter valued at about $3,251,000. Defender Capital LLC. purchased a new stake in shares of Danaher in the 4th quarter valued at about $35,715,000. Northwestern Mutual Wealth Management Co. boosted its position in shares of Danaher by 303.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after purchasing an additional 186,584 shares during the period. Finally, Coastline Trust Co boosted its position in shares of Danaher by 71.5% in the 4th quarter. Coastline Trust Co now owns 12,746 shares of the conglomerate’s stock valued at $2,918,000 after purchasing an additional 5,312 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

NYSE DHR opened at $195.75 on Friday. The firm has a market cap of $138.54 billion, a P/E ratio of 37.86, a P/E/G ratio of 2.43 and a beta of 0.79. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The business’s 50-day moving average price is $180.18 and its 200 day moving average price is $199.48. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the prior year, the business earned $1.88 EPS. The firm’s revenue was up 3.7% compared to the same quarter last year. On average, equities research analysts expect that Danaher Corporation will post 8.44 earnings per share for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is 30.95%.

Analysts Set New Price Targets

Several research analysts have commented on DHR shares. Citigroup initiated coverage on Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target on the stock. The Goldman Sachs Group decreased their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. JPMorgan Chase & Co. lowered their target price on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Rothschild & Co Redburn set a $205.00 target price on shares of Danaher in a report on Friday, April 17th. Finally, Piper Sandler began coverage on shares of Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $233.52.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.